2-28412105-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005253.4(FOSL2):āc.638G>Cā(p.Gly213Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000934 in 1,606,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005253.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOSL2 | NM_005253.4 | c.638G>C | p.Gly213Ala | missense_variant | 4/4 | ENST00000264716.9 | NP_005244.1 | |
FOSL2 | XM_006711976.4 | c.689G>C | p.Gly230Ala | missense_variant | 4/4 | XP_006712039.1 | ||
FOSL2 | XM_006711977.4 | c.572G>C | p.Gly191Ala | missense_variant | 4/4 | XP_006712040.1 | ||
FOSL2 | XM_005264231.5 | c.*123G>C | 3_prime_UTR_variant | 5/5 | XP_005264288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOSL2 | ENST00000264716.9 | c.638G>C | p.Gly213Ala | missense_variant | 4/4 | 1 | NM_005253.4 | ENSP00000264716.4 | ||
FOSL2 | ENST00000379619.5 | c.614G>C | p.Gly205Ala | missense_variant | 4/4 | 1 | ENSP00000368939.1 | |||
FOSL2 | ENST00000436647.1 | c.521G>C | p.Gly174Ala | missense_variant | 4/4 | 2 | ENSP00000396497.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000538 AC: 13AN: 241532Hom.: 0 AF XY: 0.0000608 AC XY: 8AN XY: 131622
GnomAD4 exome AF: 0.00000825 AC: 12AN: 1454076Hom.: 0 Cov.: 33 AF XY: 0.00000968 AC XY: 7AN XY: 723496
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 06, 2024 | The c.638G>C (p.G213A) alteration is located in exon 4 (coding exon 4) of the FOSL2 gene. This alteration results from a G to C substitution at nucleotide position 638, causing the glycine (G) at amino acid position 213 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at